AGC Biologics Inc.
Form 483 issued February 10, 2023 · Bothell, Washington
- Inspection
- Feb 2 – Feb 10, 2023
- Investigators
- Andrew K. Haack· Charles Yuan-Chia Kuo· Megan Dellibovi-Ragheb
- Observations
- 5
- Pages
- 15
- FEI number
- 3000209996
In short: On February 10, 2023, FDA issued a Form 483 with 5 observations to AGC Biologics Inc. in Bothell, Washington (FEI 3000209996) after an inspection that ran Feb 2 – Feb 10, 2023. The investigators were Andrew K. Haack, Charles Yuan-Chia Kuo, Megan Dellibovi-Ragheb, Michael Araneta and Zhong Li.
What FDA observed
Preview: the opening words of each observation- 01
Written records of investigations into unexplained discrepancies, the failure of a batch or any of its…
- 02
Your firm has not established adequate procedural controls to protect the electronic data acquisition and manufacturing…
- 03
There is a lack of assurance that your drug substance manufacturing operations in Building’ “at the…
- 04
Standard Operating procedures or work instructions are not…
This inspection in context
Andrew K. Haack
12 documents · 2017–2023
Cites 211.113 (control of microbiological contamination) more than any other section. Most of their documents are for sites in Washington.
The firmAGC Biologics Inc. history
All 8 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sMore form 483s
Browse other documents of this type.
Questions about this 483
What did FDA find at AGC Biologics Inc.?
FDA listed 5 observations on this Form 483. The opening words of each observation are shown on this page.
Who inspected AGC Biologics Inc.?
Andrew K. Haack, Charles Yuan-Chia Kuo, Megan Dellibovi-Ragheb, Michael Araneta and Zhong Li are named on this Form 483, for the inspection of Feb 2 – Feb 10, 2023. Each investigator has a profile showing what they cite most.
When was AGC Biologics Inc. inspected by FDA?
The inspection ran Feb 2 – Feb 10, 2023, and the Form 483 is dated February 10, 2023.
How do I get the full Form 483 for AGC Biologics Inc.?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.